These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15543085)

  • 41. Enkephalin-degrading enzymes and their inhibitors in human saliva.
    Marini M; Roda LG
    Peptides; 2000 Jan; 21(1):125-35. PubMed ID: 10704728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides.
    Shimamura M; Hazato T; Iwaguchi T
    J Biochem; 1991 Mar; 109(3):492-7. PubMed ID: 1679058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
    Palenker J; Lentzen H; Brandt U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
    Zlokovic BV; Begley DJ; Chain-Eliash DG
    Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal 4-imidazolidinone prodrugs of Leu-enkephalin: synthesis, chemical and enzymatic stability studies.
    Bak A; Fich M; Larsen BD; Frokjaer S; Friis GJ
    Eur J Pharm Sci; 1999 Mar; 7(4):317-23. PubMed ID: 9971915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
    Shimamura M; Hazato T; Hachisu M; Katayama T
    J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human brain leucyl aminopeptidase: isolation, characterization and specificity against some neuropeptides.
    Gibson AM; Biggins JA; Lauffart B; Mantle D; McDermott JR
    Neuropeptides; 1991 Jul; 19(3):163-8. PubMed ID: 1680222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of opioid peptides by cerebral microvascular aminopeptidase M.
    Churchill L; Bausback HH; Gerritsen ME; Ward PE
    Biochim Biophys Acta; 1987 Jan; 923(1):35-41. PubMed ID: 2879569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines--III. Soluble enzymes.
    Marini M; Urbani A; Bongiorno L; Roda LG
    Int J Immunopharmacol; 1992 Aug; 14(6):995-1002. PubMed ID: 1428373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial purification of two distinct enkephalin-degrading aminopeptidases from human cerebrospinal fluid.
    Hazato T; Shimamura M; Komuro T; Katayama T
    Biochem Int; 1985 May; 10(5):813-9. PubMed ID: 2409980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-induced increase of leucine enkephalin enzyme degradation in human plasma.
    Babst R; Bongiorno L; Marini M; Marzano M; Spagnoli G; Roda LG; Urbani A
    Peptides; 1998; 19(7):1155-63. PubMed ID: 9786164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro methionine5-enkephalin degradation kinetics by human brain preparations.
    Mosnaim AD; Nguyen TD; Tse R; Puente J; Couceyro P; Wolf ME
    Neurochem Res; 2008 Jan; 33(1):81-6. PubMed ID: 17676390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain.
    Zloković BV; Lipovac MN; Begley DJ; Davson H; Rakić L
    J Neurochem; 1987 Jul; 49(1):310-5. PubMed ID: 3585338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M; Bachar E; Vogel Z; Blumberg S
    Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mean daily plasma concentrations of beta-endorphin, leu-enkephalin, ACTH, cortisol, and DHEAS in epileptic patients with complex partial seizures evolving to generalized tonic-clonic seizures.
    Marek B; Kajdaniuk D; Kos-Kudła B; Kapustecki J; Swietochowska E; Ostrowska Z; Siemińska L; Nowak M; Głogowska-Szelag J; Borgiel-Marek H; Ciesielska-Kopacz N; Foltyn W; Pierzchała K; Krysiak R; Bienek R
    Endokrynol Pol; 2010; 61(1):103-10. PubMed ID: 20205112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
    Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
    Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
    Ino K; Goto S; Kosaki A; Nomura S; Asada E; Misawa T; Furuhashi Y; Mizutani S; Tomoda Y
    Biotherapy; 1991; 3(4):351-7. PubMed ID: 1786199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.